Skip to content
10-K/A

Annual Report

Rejuvel Bio-Sciences, Inc.

0001469709-15-000319

← back to feed
Filed
Jun 2, 2015 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding restated FY 2014 · Apr 15, 2015 50.47M sh
Operating Cash Flow FY 2014 · Dec 31, 2014 −$493.79K
Cash And Equivalents FY 2014 · Dec 31, 2014 $39.5K
Stockholders Equity FY 2014 · Dec 31, 2014 −$833.43K
Current Liabilities FY 2014 · Dec 31, 2014 $938.16K
Total Liabilities FY 2014 · Dec 31, 2014 $938.16K
Current Assets FY 2014 · Dec 31, 2014 $53.05K
Total Assets FY 2014 · Dec 31, 2014 $104.73K
Sga Expense FY 2014 · Dec 31, 2014 $698K
Rd Expense FY 2014 · Dec 31, 2014 $6.65K
Net Income FY 2014 · Dec 31, 2014 −$352.87K
Operating Income FY 2014 · Dec 31, 2014 −$68.71K
Gross Profit FY 2014 · Dec 31, 2014 $10.79K
Cost Of Revenue FY 2014 · Dec 31, 2014 $83.3K
Revenue FY 2014 · Dec 31, 2014 $94.1K